Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5542 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 24 25 26 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Imevax–Germany (govt): investment, 201503 KfW invests in 2nd closing of Series A financing 2015-03-02
Albiogen–Illumina: DNA sequencing technology, 201503– distribution of Illumina platforms + solutions in RU + Belarus + Kazakhstan by Albiogen 2015-03-01
APR Applied Pharma Research–HBM: investment, 201503 acquisition of €na minority stake by HBM Partners 2015-03-01
Bayer–Flagship Ventures: agri life sciences, 201503– strategic innovation partnership €na incl investment Bayer CropScience in Flagship Ventures Fund 2015-03-01
Flagship Ventures–AstraZeneca: investment, 201503 strategic investment by AstraZeneca in $537m Flagship Ventures Fund V 2015-03-01
Flagship Ventures–Bayer: investment, 201503 strategic investment €na by Bayer CropScience in $537m Flagship Ventures Fund V 2015-03-01
Flagship Ventures–Nestlé: investment, 201503 strategic investment by Nestlé Health Science in $537m Flagship Ventures Fund V 2015-03-01
Funakoshi–Genetrix (ES): nucleic acid amplification technology, 201503– distribution non-excl of Sygnis’ TruePrime products in Japan by Funakoshi 2015-03-01
Genenta Science–SEVERAL: investment, 201503 financing round Series A €10m 2015-03-01
NUA GmbH–Eurofins: investment, 201503 acquisition by Eurofins 2015-03-01
RiNA GmbH–Biotechrabbit: investment, 201503 acquisition of assets + lab + staff of bankrupt RiNA GmbH by Biotechrabbit GmbH 2015-03-01
Finistere–AVAC: investment, 201502 1st closing totalling $150m Finistere II Agtech Fund in collab w Bayer CropScience + AVAC Ltd 2015-02-25
Finistere–Bayer: investment, 201502 1st closing totalling $150m Finistere II Agtech Fund in collab w Bayer CropScience + AVAC Ltd 2015-02-25
Finistere–SEVERAL: investment, 201502 1st closing $150m Finistere II Agtech Fund in collab w Bayer CropScience + AVAC Ltd 2015-02-25
Canbex Therapeutics–Ipsen: investment, 201502 Ipsen pays €6m upfront for option to acquire Canbex upon Ph2a completion of VSN16R in MS spasticity 2015-02-24
Prexton Therapeutics–Merck (DE): investment, 201502 financing round Series A totalling €8.7m incl returning founding + co-investor MS Ventures 2015-02-24
Prexton Therapeutics–SEVERAL: investment, 201502 financing round Series A €8.7m co-led by Sunstone Capital + Ysios Capital plus MS Ventures 2015-02-24
Prexton Therapeutics–Sunstone Capital: investment, 201502 financing round Series A totalling €8.7m incl co-lead investor Sunstone Capital 2015-02-24
Prexton Therapeutics–Ysios Capital: investment, 201502 financing round Series A totalling €8.7m incl co-lead investor Ysios Capital 2015-02-24
Roche–BioMed X: bio sensors, 201502– collab new BioMed X research group to discover nanomaterial-based bio sensors for near-patient testing 2015-02-24
Heptares–Sosei: investment, 201502 acquisition 100% for $180m in cash + $220m milestones to continue as UK subsidiary 2015-02-23
NBE Therapeutics–Boehringer: investment, 201502 financing round Series A totalling CHF3m led by Boehringer Ingelheim Venture Fund 2015-02-20
NBE Therapeutics–SEVERAL: investment, 201502 financing round Series A CHF3m led by Boehringer Ingelheim Venture Fund 2015-02-20
Argenx–Lonza: gene expression system, 201502– license multi-product for GS Xceed System for production of therapeutic antibodies 2015-02-18
Boehringer–Genedata: bioinformatics, 201502– supply license to Genedata Biologics platform for BI RnD Sites in US + Europe 2015-02-18
D-Mark Biosciences–Genetrix (ES): nucleic acid amplification technology, 201502– distribution of Sygnis TruePrime Single Cell WGA kit in Canada 2015-02-18
Immunservice–High-Tech Gründerfonds: investment, 201502 financing round Series C incl existing investor HTGF 2015-02-18
Immunservice–SEVERAL: investment, 201502 financing round Series C from Michael Otto + Helmut Ponath + Hubertus-Wald-Stiftung + HTGF + Hartwig Huland 2015-02-18
Immune Targeting Systems–Vaxin: investment, 201502 acquisition merger in shares 2015-02-17
AC Immune–Michael J Fox Foundation: grant, 201502 research grant €na for developm of PET tracers for alpha-synuclein protein in Parkinson diagnosis 2015-02-12
Evotec–ChemAxon: cheminformatics, 201502– supply use of ChemAxon’s Compliance Checker to aid controlled substance management 2015-02-12
Merck (US)–XL-protein: PASylation technology, 201502– license excl ww + co-developm several biopharmaceuticals for MSD Animal Health 2015-02-12
TiGenix–Lonza: cell therapy contract manufacturing, 201502– supply of Cx601 for US phase 3 study + potentially marketing 2015-02-12
Galapagos–Flanders (govt): grant, 201502 IWT grant €1.6m to develop antiviral for hepatitis B w Univ Leuven + Univ Hospital Heidelberg 2015-02-11
GlycoVaxyn–GSK: investment, 201502 acquisition of all remaining shares for $190m by GSK 2015-02-11
Boehringer–VTU: recombinant protein production, 201502– collab ww renewal of agreem for Pichia pastoris technology 2015-02-10
JnJ–Valneva: investment, 201502 acquisition €45m of Crucell Sweden AB + affiliates incl all assets related to Dukoral 2015-02-10
Signature Diagnostics–Roche: investment, 201502 acquisition of SDx by Roche 2015-02-09
Exquiron Biotech–SAMDI Tech: drug discovery services, 201502– collab mutually co-promotion of respective services in Europe + North America 2015-02-08
Advanced Scientifics–Thermo Fisher: investment, 201502 acquisition $300m in cash 2015-02-05
Nanion–Ratos: patch clamp technology, 201502– license non-excl to key patent providing freedom-to-operate for life time of patent from Biolin 2015-02-05
SciLifeLab (SE)–Fluidigm: CyTOF mass cytometer, 201502 supply three CyTOF 2 systems to Swedish National Center for Single-Cell Analysis 2015-02-05
Zedira–Germany (govt): grant, 201502– BMBF funding €1m to support further coagulation factor XIIIa inihibitor development 2015-02-03
Zedira–Univ Marburg: structural biology, 201502 collab existent w group of Prof Gerhard Klebe 2015-02-03
Poonawalla–Genticel: vaccine technology, 201502– license to Vaxiclase platform for pertussis vaccine $57m upfront + milestones + royalties to SII 2015-02-02
R2R Biofluidics project–EU (govt): grant, 201502–201901 H2020 grant €6.4m out of total budget of €7.9m 2015-02-01
Atlas Genetics–Bellevue: investment, 201501 financing round Series C totalling $20m incl returning investor BB Biotech Ventures 2015-01-29
Atlas Genetics–Novartis: investment, 201501 financing round Series C totalling $20m incl returning investor Novartis Venture Funds 2015-01-29
Atlas Genetics–Russia (govt): investment, 201501 financing round Series C totalling $20m incl new investor RMI Partners 2015-01-29
Atlas Genetics–SEVERAL: investment, 201501 financing round Series C $20m from existing investors + new investor RMI Partners 2015-01-29
Nanocomp–Evonik: investment, 201501– strategic minority investment €na by Evonik Venture Capital 2015-01-29
Oncgnostics–High-Tech Gründerfonds: investment, 201501 financing round Series A totalling € 7-digit incl existing investor HTGF 2015-01-29
Oncgnostics–SEVERAL: investment, 201501 financing round Series A € 7-digit led by new investor bm|t 2015-01-29
Fodjan–High-Tech Gründerfonds: investment, 201501 seed investment € 6-digit by HTGF 2015-01-28
Ratos–Xention: patch clamp technology, 201501 acquisition key patent by Biolin Scientifc from Xention Ltd 2015-01-27
Dacheng–Dentons: investment, 201501– merger signed to become largest law firm ww 2015-01-26
Nanion–Tokyo Women’s Medical Univ: patch clamp system, 201501– collab optimising performance of iPS cells an Nanion systems 2015-01-22
Sigma-Aldrich–VIB: research reagents, 201501– alliance to provide products + tools + technologies for translational research 2015-01-22
BioNova Cientifica–Genetrix (ES): nucleic acid amplification technology, 201501– distribution of Sygnis TruePrime Single Cell WGA kit in Spain 2015-01-21
InnoCyte–PharmaCell: cell analysis technology, 201501– collab within Biomat-IN network to scientifically support split.it cell passage device 2015-01-21
Trophos–Roche: investment, 201501 acquisition €120m upfront cash + €350m milestones 2015-01-16
ASPEC Technologies–CovalX: mass spectrometry, 201501 collab existent ASPEC is distributor of CovalX High-Mass systems in China 2015-01-15
Sanofi–Boehringer: biologics contract manufacturing, 201501– supply strategic manufacturing alliance to supply therapeutic ABs to Sanofi 2015-01-15
Roche–Human Longevity: genome sequencing services, 201501– supply €na multi-year agreem with Genentech for whole genome sequencing + data analysis 2015-01-14
Boehringer–Vanderbilt Univ: Ras inhibitors, 201501– collab multi-year €na r+d small-molecule Ras inhibitors for cancer 2015-01-13
Boehringer–Vanderbilt Univ: Ras inhibitors, 201703– collab expansion r+d small-molecule KRAS inhibitors for cancer 2015-01-13
Boehringer–Yale Univ: immunotherapy, 201501– collab identification of targets + agents w excl licensing option for BI 2015-01-13
Cortendo–SEVERAL: investment, 201501 private placement $27.5m (SEK221m) incl RA Capital + NEA + Broadfin Capital + HealthCap 2015-01-13
GenePOC–Debiopharm: investment, 201501 financing round led by Debiopharm Diagnostics + Emerillon Capital 2015-01-13
GenePOC–SEVERAL: investment, 201501 financing round led by Debiopharm Diagnostics + Emerillon Capital 2015-01-13
Artel–Stratec: liquid handling technology, 201501– distribution excl marketing of Tholos liquid handling quality assurance instrumentation solution 2015-01-12
Foundation Medicine–Roche: investment, 201501– acquisition majority share up to 56.3% via $780m tender offer + $250m new shares $50/share 2015-01-12
JnJ–AC Immune: therapeutic vaccines, 201501– collab + license up to $509m (CHF500m) ACI-35 + 3y research therap vaccines for tauopathies 2015-01-12
Valneva–SEVERAL: investment, 201501–201502 capital increase €45m 18.23m new ordinary shares to finance acquisition of Crucell Sweden AB 2015-01-12
Qiagen–ArcherDX: DNA sequencing technology, 201501– distribution €na of Archer NGS products by Qiagen 2015-01-11
Agenus–Incyte: investment, 201501 equity investment $35m at $4.51/share by Incyte as part of ww cancer immunotherapy alliance 2015-01-09
Incyte–Agenus: cancer immunotherapy, 201501– collab ww alliance $25m upfront + $350m milestones + $35m equity investment using Retrocyte Display techn 2015-01-09
Haplogen–Horizon Discovery: investment, 201501 acquisition of Haplogen Genomics GmbH for upfront €3.8m cash + €3.8m shares + €5m milestones in shares 2015-01-08
Miracor–SEVERAL: investment, 201501 financing round Series B extension €4.5m from BioMedInvest + AWS + SHS + Earlybird + Delta Partners 2015-01-08
Addex–United States (govt): ADX71441, 201501– collab NIAAA to evaluate ADX71441 in preclinical models of alcohol use disorder 2015-01-07
Affimed–Germany (govt): grant, 201501– BMBF grant €2.4m to develop Trispecfic ABs within KMUinnovative BioChance program 2015-01-07
Affimed–MacDougall Biomedical Communications: public relations, 201501 service existent by MacDougall Munich Office 2015-01-07
Caribou Biosciences–Novartis: investment, 201501 equity investment by Novartis in connection w collab + license agreement 2015-01-07
Close Brothers–Oddo: investment, 201501 acquisition of Close Brothers Seydler Bank AG by Oddo & Cie 2015-01-07
Genkyotex–SEVERAL: investment, 201501 financing round Series D CHF20m=$21m led by new investor NeoMed Management 2015-01-07
Intellia Therapeutics–Novartis: investment, 201501 increase of equity investment by Novartis 2015-01-07
Novartis–Caribou Biosciences: CRISPR technology, 201501– collab + license agreem non-excl for devlopm of drug discovery tools 2015-01-07
Novartis–Intellia Therapeutics: CRISPR technology, 201501– collab + license agreem incl upfront paym + investm + funding + milestones + royalties 2015-01-07
Gilead–Phenex: FXR agonists, 201501 acquisition of Phenex’ FXR agonists program for NASH + other liver diseases for up to $470m 2015-01-06
OnCore BioPharma–Cytos Biotechnology: VLP technology, 201501– license to OnCore excl for use of VLP platform in treatm + prevention of HBV infections 2015-01-06
Provendis–TVM: venture capital, 201501– collab support in project evaluation + financing by TVM Capital Life Science for projects of Provendis 2015-01-06
Boehringer–BioMed X: pharma research, 201501– collab new BioMed X research group to discover new epigenetic COPD regulators 2015-01-05
Redbiotec–Pfizer: investment, 201501 acquisition of controlling interest in Redvax GmbH, a spin-off from Redbiotec AG 2015-01-05
Aevotis–Evocatal: investment, 201501 acquisition €na of majority stake by Evocatal 2015-01-01
Atomwise–SEVERAL: investment, 2015 seed financing round incl Y Combinator + Khosla Ventures + DJF 2015-01-01
Bayer–Proteros: drug discovery services, 201501–201612 collab identification of cardiovascular compounds for integral membrane protein 2015-01-01
Biocentric–Hain Lifescience: investment, 2015 acquisition of Biocentric by Hain 2015-01-01
EffRx–SEVERAL: investment, 201501 financing round CHF2.3m from existing investors 2015-01-01
GreenBone–SEVERAL: investment, 2015 seed financing round €3m from ZernikeMeta Ventures + Italian Angels for Growth + private investors 2015-01-01
IFM Therapeutics–Atlas Venture: investment, 2015 seed funding by Atlas Venture 2015-01-01
next pagenext page 1 2 3 ... 24 25 26 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top